Yu Li

4.6k total citations · 1 hit paper
183 papers, 3.1k citations indexed

About

Yu Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Li has authored 183 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 75 papers in Cancer Research and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Li's work include Cancer-related molecular mechanisms research (41 papers), MicroRNA in disease regulation (30 papers) and Circular RNAs in diseases (26 papers). Yu Li is often cited by papers focused on Cancer-related molecular mechanisms research (41 papers), MicroRNA in disease regulation (30 papers) and Circular RNAs in diseases (26 papers). Yu Li collaborates with scholars based in China, United States and Australia. Yu Li's co-authors include Junfeng Wang, Honggang Pang, Jinning Song, Guoan Chen, Yuhui Du, Qingxue Zhang, Xinwei Huang, Liqiong Guo, Minghui Chen and Xiangyang Kong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Yu Li

167 papers receiving 3.0k citations

Hit Papers

Iron and copper: critical executioners of ferroptosis, cu... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death
    2023 106 citations Yu Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Li China 30 1.7k 776 332 279 266 183 3.1k
Yan Zhou China 35 1.7k 1.0× 572 0.7× 306 0.9× 334 1.2× 446 1.7× 135 3.4k
Bin Xiao China 31 1.9k 1.1× 801 1.0× 204 0.6× 260 0.9× 211 0.8× 163 3.3k
Tianyi Liu China 26 1.7k 1.0× 615 0.8× 197 0.6× 380 1.4× 260 1.0× 119 3.7k
Bo Chen China 30 2.1k 1.2× 710 0.9× 312 0.9× 224 0.8× 126 0.5× 166 3.6k
Yujing Liu China 30 1.5k 0.9× 421 0.5× 230 0.7× 345 1.2× 256 1.0× 166 3.3k
Tapati Chakraborti India 25 1.3k 0.8× 699 0.9× 241 0.7× 340 1.2× 191 0.7× 107 3.3k
He Zhang China 36 2.1k 1.2× 868 1.1× 176 0.5× 449 1.6× 153 0.6× 132 3.7k
Jihong Zhang China 26 1.6k 0.9× 639 0.8× 184 0.6× 171 0.6× 233 0.9× 218 2.8k

Countries citing papers authored by Yu Li

Since Specialization
Citations

This map shows the geographic impact of Yu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Li more than expected).

Fields of papers citing papers by Yu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Li. The network helps show where Yu Li may publish in the future.

Co-authorship network of co-authors of Yu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Li. A scholar is included among the top collaborators of Yu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Li. Yu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bowen, et al.. (2025). Pharmacological inhibition of Kv1.3 channel reduces sevoflurane-induced cognitive impairment through NLRP3-dependent microglial modulation. Brain Research Bulletin. 225. 111351–111351. 2 indexed citations
2.
Chen, Linbo, Chuyi Zhang, Jiangshan Chen, et al.. (2025). Microglia contribute to bipolar depression through Serinc2-dependent phospholipid synthesis. Proceedings of the National Academy of Sciences. 122(37). e2500116122–e2500116122.
3.
Huang, Junjie, Laiang Yao, Minmin Wang, et al.. (2024). IDDF2024-ABS-0455 Global epidemiology of liver cancer subtypes: insights from a comprehensive analysis. A275.1–A275.
4.
5.
Li, Yu, et al.. (2024). PDCD4 promotes inflammation/fibrosis by activating the PPAR‑γ/NF‑κB pathway in mouse atrial myocytes. Molecular Medicine Reports. 30(5). 4 indexed citations
6.
Li, Yu, et al.. (2024). Growth differentiation factor 15: Emerging role in liver diseases. Cytokine. 182. 156727–156727. 13 indexed citations
7.
Li, Yu, et al.. (2024). Low-carbon and overproduction of cordycepin from methanol using engineered Pichia pastoris cell factory. Bioresource Technology. 413. 131446–131446. 10 indexed citations
8.
Zhao, Ying, Wenfeng Luo, Xiaoyu Song, et al.. (2024). PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming. The International Journal of Biochemistry & Cell Biology. 169. 106554–106554. 9 indexed citations
9.
Li, Keliang, Shanchao Wu, Gaopan Dong, et al.. (2023). Environmentally sensitive fluorescent probes with improved properties for detecting and imaging PDEδ in live cells and tumor slices. Chinese Chemical Letters. 34(11). 108231–108231. 6 indexed citations
10.
Li, Yu, Bo Xiong, Yilong Miao, & Qian Gao. (2023). Silibinin supplementation ameliorates the toxic effects of butyl benzyl phthalate on porcine oocytes by eliminating oxidative stress and autophagy. Environmental Pollution. 329. 121734–121734. 6 indexed citations
11.
Li, Yu, Bin Pan, Feiyang Zhang, et al.. (2023). TPI1 promotes MAPK/ERK‐induced EMT, cell migration and invasion in lung adenocarcinoma. Thoracic Cancer. 15(4). 327–338. 5 indexed citations
12.
Li, Yu, et al.. (2023). Discovery of Novel PDEδ Autophagic Degraders: A Case Study of Autophagy-Tethering Compound (ATTEC). ACS Medicinal Chemistry Letters. 15(1). 29–35. 17 indexed citations
13.
Ding, Yixin, Shufen Zhao, Yu Li, et al.. (2023). Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression. International Journal of General Medicine. Volume 16. 4883–4906. 2 indexed citations
14.
15.
Li, Yu, et al.. (2023). Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer. International Journal of Pharmaceutics. 648. 123583–123583. 11 indexed citations
16.
He, Shipeng, et al.. (2022). Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells. ACS Medicinal Chemistry Letters. 13(2). 298–303. 15 indexed citations
17.
Fang, Kun, Guoqiang Dong, Yu Li, et al.. (2018). Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors. ACS Medicinal Chemistry Letters. 9(4). 312–317. 51 indexed citations
18.
Zhang, Jian‐Guo, Yu Li, & Wei Zhou. (2012). Role of CXCR4 in human glioma angiogenesis. Chinese Journal of Neuromedicine. 11(7). 681–683. 1 indexed citations
19.
Li, Yu. (2010). Clinical application and research process of novel antitumor drug. Zhongguo xin yao zazhi. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Zhou Breakdown of academic impact, for papers by Bin Xiao Breakdown of academic impact, for papers by Tianyi Liu Breakdown of academic impact, for papers by Bo Chen Breakdown of academic impact, for papers by Yujing Liu Breakdown of academic impact, for papers by Tapati Chakraborti Breakdown of academic impact, for papers by He Zhang Breakdown of academic impact, for papers by Jihong Zhang
Rankless by CCL
2026